SLNCF — Silence Therapeutics Share News
0.000.00%
- $902.88m
- $830.82m
- $0.56m
Silence Therapeutics - Silence to Partake in March Investor Conferences
Silence Therapeutics - Silence to present at SVB Leerink Conference
Brief: Silence Therapeutics Initiates Dosing In Phase 1 Clinical Trial Of Sln360 For Cardiovascular Disease
Silence Therapeutics - First dosing for SLN360
Silence Therapeutics - Holding(s) in Company
Silence Therapeutics - Holding(s) in Company
Silence Therapeutics - Holding(s) in Company
Silence Therapeutics - Holding(s) in Company
Silence Therapeutics - Additional Listing and Total Voting Rights
Silence Therapeutics - Holding(s) in Company
Silence Therapeutics - Holding(s) in Company
Silence Therapeutics - Additional listing and Total Voting Rights
Brief: Silence Therapeutics PLC Announces $45 Million Private Placement
Brief: Silence Therapeutics Announces $45M Private Placement
Silence Therapeutics - Silence Announces $45m Private Placement
Silence Therapeutics - Additional listing and Total Voting Rights
Silence Therapeutics - Additional listing and Total Voting Rights
Silence Therapeutics - Holdings in Company
Silence Therapeutics - Grant of Options